RenBio was founded on the principle that the remarkable medical benefits of antibody therapeutics should be available to everyone, and was named one of DARPA’s “Biotech Startups of the Future” one year after opening its operations. The company was co-founded by David D. Ho, MD (Time magazine's "Man of the Year" in 1996 and recipient of the Presidential Citizens Medal) and Yaoxing Huang, PhD, visionary scientists affiliated with the Aaron Diamond AIDS Research Center and Professors at Columbia University Medical Center. RenBio is backed by the Bill & Melinda Gates Foundation, DARPA, BARDA, Wellcome Trust, and a syndicate of private investors, and is headquartered in New York City.
| Website | http://www.renbio.com |
| Employees | 8 (6 on RocketReach) |
| Technologies |
JavaScript
,
HTML
,
PHP
+18 more
(view full list)
|
| Industry | Biotechnology Research |
| Keywords | Antibody Therapeutics, Biotechnology, Pharmaceutical Research, Drug Development, Biologics, Therapeutic Antibodies, Immunotherapy, Precision Medicine, Biopharmaceutical, Clinical Trials, Medical Research, Drug Discovery, Protein Engineering, Pharmaceutical, Therapeutics, Health, Medicine, Treatment, Healthcare |
| Competitors | Johnson & Johnson, Roche, AbbVie, Bristol Myers Squibb, Gilead Sciences, Pfizer, Amgen, Novartis, Sanofi, Merck AH +35 more (view full list) |
Looking for a particular RenBio employee's phone or email?
Rachel Liberatore is the President and Chief Scientific Officer of RenBio.
6 people are employed at RenBio.